Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial

1 Feb 2001

Abstract excerpt

Previous studies have demonstrated that the use of recombinant human follicle stimulating hormone (rhFSH) for ovarian stimulation may be associated with a better outcome than human menopausal gonadotrophin (HMG), probably due to the absence of LH, higher FSH bioactivity and better quality of oocytes and embryos when rhFSH is used. Very few studies have examined the effects of different gonadotrophins on oocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility
Share to Sperm and Testicular Function

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11157827
DOI: 10.1093/humrep/16.2.319

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trialPMID 11157827Read ↗

The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trialSemantic proximity Read ↗

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVFSemantic proximity Read ↗

Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSHSemantic proximity Read ↗

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injectionSemantic proximity Read ↗

Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSHSemantic proximity Read ↗

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphologySemantic proximity Read ↗

Effect of recombinant human gonadotrophins on human, bovine and murine oocyte meiosis, fertilization and embryonic development in vitroSemantic proximity Read ↗

Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized studySemantic proximity Read ↗

Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cyclesSemantic proximity Read ↗

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulationSemantic proximity Read ↗

Embryo quality in natural versus stimulated IVF cyclesSemantic proximity Read ↗

Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.